To: Banking System Observers
From: David O'Neill Losier
Date: December 7, 2021
Re: Let’s Give Credit Unions a Fighting Chance in the Digital Age
Payments Canada recently declared that the “radical shift in purchasing behaviours since the onset of COVID-19 continues” as online payments surge.
S3 E21: Canada's $2 Trillion Dollar Transition
In part one of a two-part series, RBC’s John Stackhouse and Cynthia Leach join our Michael Hainsworth to discuss the road to reducing Canada's 730 million tonnes GHG to net-zero. With COP26 now behind us, the hard work of selling climate change action at home begins and Canada’s biggest bank has spent the last year investigating how best to shift to a net zero policy by 2050, or sooner, and calls it "The $2T Transition."
Credit Unions Must Go Big on Digital, Scale up to Thrive
November 2, 2021 – Credit unions face urgent challenges in the digital revolution, including the need for large new investments in technology and room to expand, according to a new report from the C.D. Howe Institute. With the digital revolution underway, most credit unions outside of Quebec are falling behind when it comes to making the significant investments required for the next decade, states the report.
From: Wes Funk, Stephen Lougheed, Tracey McCrimmon and Gerard Protti
To: Environment Minister Steven Guilbeault and Natural Resources Minister Jonathan Wilkinson
Date: November 1, 2021
Re: Measurement and Regulation of Methane Emissions
From: Alexandre Laurin
To: Finance Minister Chrystia Freeland
Date: October 14, 2021
Re: Tracking Capital Gains: Not Just for the Rich
Government deficits, along with distributional concerns, have fueled calls for heavier taxation of capital gains in recent years. Yesterday, we examined modelling around taxpayer responses to any increases.
From: Åke Blomqvist and Paul Grootendorst
To: Canadians Concerned about Drug Prices
Date: October 12, 2021
Re: Price Regulation Not the Best Answer for Pharmaceuticals
Big changes are afoot in the way patent drugs are priced in Canada. At present, Canada’s Patented Medicine Prices Review Board (PMPRB), a federal agency, is responsible for setting maximum prices for patented drugs (i.e., pharmaceuticals, biologics and vaccines).
To: Canadians concerned about healthcare
From: Janice MacKinnon
Date: October 6, 2021
Re: Saskatchewan Model Shows How Private Clinics Can Play in a Public System
From: Martin Eichenbaum
To: Canadian deficit watchers
Date: October 1, 2021
Re: Meet r Minus g: A New Way to Worry about Deficit Spending
Should Canadians worry about the level of government debt when interest rates are so low?
Yes. But the primary danger doesn’t come so much from Canada. Instead, it comes from the fiscal behavior of the US government.